Jennifer N. Choi, MD, FAAD
SESSIONS
F021 New Drugs, New Rashes: An Update on Cutaneous Drug Eruptions
Mar 7, 2025
•
1:00 PM - 3:00 PM
•
W314B
U043 Toxic Erythema of Chemotherapy: Comprehensive Approach to Diagnosis and Management
Mar 8, 2025
•
4:30 PM - 5:30 PM
•
W304E
F102 A Primer and Practical Approach to Cancer Checkpoint Inhibitors for the Dermatologist
Mar 10, 2025
•
3:30 PM - 5:30 PM
•
W303A
DISCLOSURES
Azitra, Inc – Advisory Board(Fees); CeraVe/Valeante – Independent Contractor(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Global Services, LLC – Advisory Board(Fees); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); OnQuality Pharmaceuticals, Ltd. – Advisory Board(Fees); Parexel – Data Safety Monitoring Board(Fees); PraHealth Sciences – Advisory Board(Fees); Regeneron Pharmaceuticals, Inc. – Data Safety Monitoring Board(Fees);